Office of the Secretary; Notice of Meeting, 58918-58919 [2021-23191]

Download as PDF jspears on DSK121TN23PROD with NOTICES1 58918 Federal Register / Vol. 86, No. 203 / Monday, October 25, 2021 / Notices economic threshold and is not considered a major notice. The RFA requires agencies to analyze options for regulatory relief of small businesses. For purposes of the RFA, small entities include small businesses, nonprofit organizations, and small governmental jurisdictions. Most hospitals and most other providers and suppliers are small entities, either by nonprofit status or by having revenues of less than $7.5 million to $38.5 million in any 1 year. Individuals and states are not included in the definition of a small entity. As we stated in the RIA for the February 2, 2011 final rule with comment period (76 FR 5952), we do not believe that the application fee will have a significant impact on small entities. In addition, section 1102(b) of the Act requires us to prepare a regulatory impact analysis if a rule may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area for Medicare payment regulations and has fewer than 100 beds. We are not preparing an analysis for section 1102(b) of the Act because we have determined, and the Secretary certifies, that this notice would not have a significant impact on the operations of a substantial number of small rural hospitals. Section 202 of the Unfunded Mandates Reform Act of 1995 (UMRA) also requires that agencies assess anticipated costs and benefits before issuing any rule whose mandates require spending in any 1 year of $100 million in 1995 dollars, updated annually for inflation. In 2021, that threshold was approximately $158 million. The Agency has determined that there will be minimal impact from the costs of this notice, as the threshold is not met under the UMRA. Executive Order 13132 establishes certain requirements that an agency must meet when it promulgates a proposed rule (and subsequent final rule) that imposes substantial direct requirement costs on state and local governments, preempts state law, or otherwise has federalism implications. Since this notice does not impose substantial direct costs on state or local governments, the requirements of Executive Order 13132 are not applicable. B. Costs The costs associated with this notice involve the increase in the application VerDate Sep<11>2014 18:00 Oct 22, 2021 Jkt 256001 fee amount that certain providers and suppliers must pay in CY 2022. The CY 2022 cost estimates are as follows: 1. Medicare Based on CMS data, we estimate that in CY 2022 approximately— • 10,214 newly enrolling institutional providers will be subject to and pay an application fee; and • 42,117 revalidating institutional providers will be subject to and pay an application fee. Using a figure of 52,331 (10,214 newly enrolling + 42,117 revalidating) institutional providers, we estimate an increase in the cost of the Medicare application fee requirement in CY 2022 of $1,674,592 (or 52,331 × $32 (or $631 minus $599)) from our CY 2021 projections. 2. Medicaid and CHIP Based on CMS and state statistics, we estimate that approximately 30,000 (9,000 newly enrolling + 21,000 revalidating) Medicaid and CHIP institutional providers will be subject to an application fee in CY 2022. Using this figure, we project an increase in the cost of the Medicaid and CHIP application fee requirement in CY 2022 of $960,000 (or 30,000 × $32 (or $631 minus $599)) from our CY 2021 projections. 3. Total Based on the foregoing, we estimate the total increase in the cost of the application fee requirement for Medicare, Medicaid, and CHIP providers and suppliers in CY 2022 to be $2,634,592 ($1,674,592 + $960,000) from our CY 2021 projections. In accordance with the provisions of Executive Order 12866, this notice was reviewed by the Office of Management and Budget. The Administrator of the Centers for Medicare & Medicaid Services (CMS), Chiquita Brooks-LaSure, having reviewed and approved this document, authorizes Lynette Wilson, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Dated: October 19, 2021. Lynette Wilson, Federal Register Liaison, Centers for Medicare & Medicaid Services. [FR Doc. 2021–23143 Filed 10–22–21; 8:45 am] BILLING CODE 4120–01–P PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Library of Medicine Special Emphasis Panel; U24. Date: December 10, 2021. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Video Assisted Meeting. Contact Person: Manana Sukhareva, Ph.D., Director, Office of Scientific Review, NIBIB/ NIH, 6707 Democracy Boulevard, Suite 920, Bethesda, MD 20892–5496, 301–451–3397, sukharem@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–23134 Filed 10–22–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Pain Research Coordinating Committee. The meeting will be open to the public. Individuals who plan to participate and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Interagency Pain Research Coordinating Committee. E:\FR\FM\25OCN1.SGM 25OCN1 58919 Federal Register / Vol. 86, No. 203 / Monday, October 25, 2021 / Notices Date: November 22, 2021. Time: 10:00 a.m. to 4:00 p.m. Eastern Time (ET). Agenda: The meeting will cover committee business items including updates on pain workforce enhancement and pain research concepts. It will include follow up of IPRCC recommendations and member updates. Webcast Live: http://videocast.nih.gov/. Deadline: Submission of intent to submit written/electronic statement for comments: Monday, November 15th, by 5:00 p.m. ET. Place: National Institutes of Health, Building 31, 31 Center Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain Policy and Planning, Office of the Director, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, Bethesda, MD 20892, Phone: (301) 451–4460, Email: Linda.Porter@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. The meeting will be open to the public via NIH Videocast https://videocast.nih.gov/. Visit the IPRCC website for more information: http://iprcc.nih.gov. Agenda and any additional information for the meeting will be posted when available. Dated: October 19, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Institutional Training Mechanism Study Section. Date: December 10, 2021. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208–Y, Bethesda, MD 20892, (301) 827–7911, lindsay.garvin@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: October 19, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–23192 Filed 10–22–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2021–23191 Filed 10–22–21; 8:45 am] BILLING CODE 4140–01–P Substance Abuse and Mental Health Services Administration DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency Information Collection Activities: Submission for OMB Review; Comment Request National Institutes of Health Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer at (240) 276–0361. jspears on DSK121TN23PROD with NOTICES1 National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant Project: Minority AIDS InitiativeManagement Reporting Tools (MAI– MRTs)—(OMB No. 0930–0357)— Revision The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP) is requesting from the Office of Management and Budget (OMB) approval for the revised Minority AIDS Initiative (MAI) monitoring tools, which includes both youth and adult questionnaires as well as the quarterly progress report. This renewal includes the inclusion of new cohorts. The cohorts of grantees funded by the MAI and included in this clearance request are: • Capacity Building Initiative 2017 • Capacity Building Initiative 2018 • Prevention Navigators 2017 • Prevention Navigators 2019 • Prevention Navigators 2020 • Prevention Navigators 2021 The target population for the MAI grantees will be at-risk minority adolescents and young adults. All MAI grantees are expected to report their monitoring data using SAMHSA’s Strategic Prevention Framework (SPF) to target minority populations, as well as other high-risk groups residing in communities of color with high prevalence of Substance Abuse and HIV/AIDS. The primary objectives of the monitoring tools include: • Assess the success of the MAI in reducing risk factors and increasing protective factorsassociated with the transmission of the Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and other sexually transmitted diseases (STD). • Measure the effectiveness of evidence-based programs and infrastructure development activities such as: Outreach and training, mobilization of key stakeholders, substance abuse and HIV/AIDS counseling and education, testing, referrals to appropriate medical treatment and/or other intervention strategies (i.e., cultural enrichment activities, educational and vocational resources, social marketing campaigns, and computer-based curricula). • Investigate intervention types and features that yield the best outcomes for specific population groups. • Assess the extent to which access to health care was enhanced for population groups and individuals vulnerable to behavioral health disparities residing in communities targeted by funded interventions. • Assess the process of adopting and implementing the SPF with the target populations. TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN Number of respondents Type of respondent activity Quarterly Progress Report ................................................. VerDate Sep<11>2014 18:00 Oct 22, 2021 Jkt 256001 PO 00000 Frm 00061 Responses per respondent 197 Fmt 4703 Sfmt 4703 Total responses 4 E:\FR\FM\25OCN1.SGM 732 25OCN1 Hours per response Total burden hours 4 2,928

Agencies

[Federal Register Volume 86, Number 203 (Monday, October 25, 2021)]
[Notices]
[Pages 58918-58919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23191]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Interagency Pain 
Research Coordinating Committee.
    The meeting will be open to the public. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Interagency Pain Research Coordinating 
Committee.

[[Page 58919]]

    Date: November 22, 2021.
    Time: 10:00 a.m. to 4:00 p.m. Eastern Time (ET).
    Agenda: The meeting will cover committee business items 
including updates on pain workforce enhancement and pain research 
concepts. It will include follow up of IPRCC recommendations and 
member updates.
    Webcast Live: http://videocast.nih.gov/.
    Deadline: Submission of intent to submit written/electronic 
statement for comments: Monday, November 15th, by 5:00 p.m. ET.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain 
Policy and Planning, Office of the Director, National Institute of 
Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, 
Bethesda, MD 20892, Phone: (301) 451-4460, Email: 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The meeting will be open to the public via NIH Videocast https://videocast.nih.gov/. Visit the IPRCC website for more information: 
http://iprcc.nih.gov. Agenda and any additional information for the 
meeting will be posted when available.

    Dated: October 19, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-23191 Filed 10-22-21; 8:45 am]
BILLING CODE 4140-01-P